Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Randomized Trial of Tenecteplase to Treat Severe Submassive Pulmonary Embolism

Trial Profile

Randomized Trial of Tenecteplase to Treat Severe Submassive Pulmonary Embolism

Completed
Phase of Trial: Phase III

Latest Information Update: 14 Aug 2013

At a glance

  • Drugs Tenecteplase (Primary) ; Enoxaparin sodium
  • Indications Pulmonary embolism
  • Focus Adverse reactions
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 10 Mar 2013 Results presented at the 62nd Annual Scientific Session of the American College of Cardiology.
    • 10 Mar 2013 Status changed from recruiting to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top